A detailed history of Pallas Capital Advisors LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 14,079 shares of BCRX stock, worth $127,555. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,079
Previous 19,797 28.88%
Holding current value
$127,555
Previous $155,000 18.71%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

SELL
$6.41 - $11.19 $36,652 - $63,984
-5,718 Reduced 28.88%
14,079 $126,000
Q1 2025

Apr 14, 2025

BUY
$7.06 - $9.39 $139,766 - $185,893
19,797 New
19,797 $155,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.68B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.